CRUS insider Andrew Brannan reports option exercises and stock sales
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Cirrus Logic, Inc. executive reports option exercises and share sales. On 11/14/2025, EVP, Worldwide Sales Andrew Brannan exercised non-qualified stock options for 595 shares at $68.56 and 7,406 shares at $78. He then reported sales of 595 shares at $117.44, 7,406 shares at a weighted average price of $119.39, and 912 shares at $117.44 under a Rule 10b5-1 trading plan adopted on August 15, 2025. Following these transactions, he reported owning 5,950 shares of Cirrus Logic common stock directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 8,913 shares ($1,061,184)
Net Sell
7 txns
Insider
Brannan Andrew
Role
EVP, Worldwide Sales
Sold
8,913 shs ($1.06M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) | 595 | $0.00 | -- |
| Exercise | Non-Qualified Stock Option (right to buy) | 7,406 | $0.00 | -- |
| Exercise | Common Stock | 595 | $68.56 | $41K |
| Sale | Common Stock | 595 | $117.44 | $70K |
| Exercise | Common Stock | 7,406 | $78.00 | $578K |
| Sale | Common Stock | 7,406 | $119.39 | $884K |
| Sale | Common Stock | 912 | $117.44 | $107K |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) — 0 shares (Direct);
Common Stock — 7,457 shares (Direct)
Footnotes (1)
- This transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 15, 2025. The price reported in Table I - Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.78 to $120.40. The reporting person will provide full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to any security holder of Cirrus Logic, Inc. or the staff of the SEC upon request. Only vested shares can be exercised under this option. 25% of the shares vested on 11/6/20; the remaining shares vested monthly over the following 36 months so that the option was fully vested and exercisable on 11/6/23. Only vested shares can be exercised under this option. 25% of the shares vested on 3/3/22; the remaining shares vested monthly over the following 36 months so that the option was fully vested and exercisable on 3/3/25.
FAQ
What did Cirrus Logic (CRUS) executive Andrew Brannan report on this Form 4?
He reported exercising non-qualified stock options for 595 shares at $68.56 and 7,406 shares at $78, and selling 595 shares at $117.44, 7,406 shares at a weighted average $119.39, and 912 shares at $117.44 of Cirrus Logic common stock on 11/14/2025.
Were the Cirrus Logic (CRUS) trades made under a Rule 10b5-1 plan?
Yes. The filing states that the transactions were made under a Rule 10b5-1 trading plan adopted by Andrew Brannan on August 15, 2025.
What are the details of the stock options exercised by the Cirrus Logic (CRUS) executive?
He exercised two non-qualified stock options: one covering 595 shares at $68.56 expiring on 11/06/2029, and another covering 7,406 shares at $78 expiring on 03/03/2031. Both options were fully vested before exercise.
What vesting schedules applied to the Cirrus Logic stock options reported?
For the option at $68.56, 25% vested on 11/06/2020 and the rest monthly over the next 36 months, becoming fully vested on 11/06/2023. For the option at $78, 25% vested on 03/03/2022 and the remainder monthly over 36 months, becoming fully vested on 03/03/2025.